Veterinarians that specialise in companion animals work in private clinics and hospitals. Cats and dogs are the most common creatures they care for, but they also treat birds, ferrets, and rabbits. Captopril, eptifibatide (Integrilin), lepirudin, and exenatide are examples of modern pharmaceuticals developed from animal venoms, poisons, or secretions (Byetta).
The market will grow as new products for companion animals with enhanced veterinary medications are introduced as a result of increased R&D spending. The market will grow due to rising demand for Companion Animal Drugs, such as parasiticides, to protect pets against fleas, parasites, ticks, and even mosquitoes. Another important issue driving demand for companion animal drugs is the rise in animal obesity.
Consumer knowledge of animal health is increasing, and favourable government policies promoting the acceptance of veterinary care goods are also helping to grow the market. The rising prevalence of diseases in pets necessitates proper animal therapy, resulting in a spike in companion animal medications. Growing obesity rates in companion animals, a growing desire for obtaining medications from online pharmacies, and rising pet adoption rates in homes are all driving market expansion.
Read More@ https://bit.ly/3kFOGt6
